Cargando…

Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis

BACKGROUND: Lymphatic filariasis (LF) infection is generally diagnosed through parasitological identification of microfilariae (mf) in the blood. Although historically the most commonly used technique for counting mf is the thick blood smear based on 20 µl blood (TBS20), various other techniques and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinkeles Melchers, Natalie V. S., Coffeng, Luc E., de Vlas, Sake J., Stolk, Wilma A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288683/ https://www.ncbi.nlm.nih.gov/pubmed/32527335 http://dx.doi.org/10.1186/s13071-020-04144-9

Ejemplares similares

Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa
por: Stolk, Wilma A., et al.
Publicado: (2022)

An investigation of the disparity in estimates of microfilaraemia and antigenaemia in lymphatic filariasis surveys
por: Cano, Jorge, et al.
Publicado: (2015)

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
por: Stolk, Wilma A, et al.
Publicado: (2006)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2018)

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold
por: Prada, Joaquin M, et al.
Publicado: (2020)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination
por: Michael, Edwin, et al.
Publicado: (2018)

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages
por: de Vos, Anneke S., et al.
Publicado: (2021)

Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys
por: Berg Soto, Alvaro, et al.
Publicado: (2018)

Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies
por: Prada, Joaquín M, et al.
Publicado: (2021)

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis
por: de Vos, Anneke S., et al.
Publicado: (2018)

Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models
por: Stolk, Wilma A, et al.
Publicado: (2018)

Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities
por: Biritwum, Nana Kwadwo, et al.
Publicado: (2019)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
por: Stolk, Wilma A., et al.
Publicado: (2015)

Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring
por: Hamley, Jonathan I D, et al.
Publicado: (2020)

Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness
por: Bhattacharyya, Samit, et al.
Publicado: (2023)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes
por: Lont, Yvonne L., et al.
Publicado: (2017)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
por: Jambulingam, Purushothaman, et al.
Publicado: (2016)

Canine microfilaraemia in some regions of Iran
por: Hosseini, Seyed Hossein, et al.
Publicado: (2022)

Temporal variability of Loa loa microfilaraemia
por: Campillo, Jérémy T., et al.
Publicado: (2023)

Achieving herd immunity against COVID-19 at the country level by the exit strategy of a phased lift of control
por: de Vlas, Sake J., et al.
Publicado: (2021)

Two-stage lot quality assurance sampling framework for monitoring and evaluation of neglected tropical diseases, allowing for imperfect diagnostics and spatial heterogeneity
por: Kazienga, Adama, et al.
Publicado: (2022)

Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025
por: Vinkeles Melchers, Natalie V S, et al.
Publicado: (2020)

Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework
por: Smith, Morgan E., et al.
Publicado: (2017)

African Program for Onchocerciasis Control 1995–2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases
por: Krotneva, Stanimira P., et al.
Publicado: (2015)

Sensitivity analysis and parameters estimation for the transmission of lymphatic filariasis
por: Stephano, Mussa A., et al.
Publicado: (2023)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Recombinant antigens used as diagnostic tools for lymphatic filariasis
por: Pastor, André Filipe, et al.
Publicado: (2021)

Antibody and Antigen Prevalence as Indicators of Ongoing Transmission or Elimination of Visceral Leishmaniasis: A Modeling Study
por: Coffeng, Luc E, et al.
Publicado: (2021)

Prevalence of malaria and lymphatic filariasis in bateyes of the Dominican Republic
por: Keys, Hunter M., et al.
Publicado: (2019)

Mapping the baseline prevalence of lymphatic filariasis across Nigeria
por: Eneanya, Obiora A., et al.
Publicado: (2019)

Feasibility of controlling hookworm infection through preventive chemotherapy: a simulation study using the individual-based WORMSIM modelling framework
por: Coffeng, Luc E., et al.
Publicado: (2015)

Appropriateness of the current parasitological control target for hookworm morbidity: A statistical analysis of individual-level data
por: Malizia, Veronica, et al.
Publicado: (2022)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Mapping of lymphatic filariasis in Nepal
por: Sherchand, Jeevan B, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_3cehk0iu4jb9lvfs9ch8maqav4